|
|
Informa Life Sciences
|
|
| Medical Device Regulations 2007 |
|
|
|
|
|
|
| |
|
 |
|
|
|
|
| |
|
|
v The latest revisions to the Medical Devices Directive and their impact on your business
v Obtaining the CE mark for your product
v The essentials for classification
v Understanding the difference between the literature route and clinical investigations
v The importance of essential requirements
v The potential pitfalls of labelling, e-labelling and instruction of use
v Ensure adequate risk management is in place
v Create and implement a quality system
v The importance of maintaining post market surveillance and vigilance systems
|
|
|
Who Will Attend?
This is ideal for newcomers to the industry or for those who are looking for a refresher in Medical Device regulations.
- Regulatory Affairs Professionals
- Quality Assurance Professionals
- Sales & Marketing Managers
- Product Development Managers
- Technical Managers
|
Don't Miss
Pre-Course Workshop: 22 May 2007
Introduction to US FDA Regulation of Medical Devices
• Statutory basis for FDA regulation of medical devices in the US, including relevant regulations
• FDA organisational structure
• Risk-based classification system for medical devices plus general and specific controls
• Investigational devices
• Types of submissions
• Pathways to market, including premarket notification 510(k) and premarket approval (PMA)
• Additional requirements for marketing, including registration and listing, labelling, quality system regulation (QSR), and medical device reporting (MDR)
• Working with the Center for Devices and Radiological Health (CDRH)
Course Leader: Trevor Lewis, Principal Consultant, Medical Device Consultancy, UK
Post-Course Workshop: 25 May 2007
An introduction to Japanese regulations for Medical Devices
An increasing number of medical device manufacturers are manufacturing and selling their products in the Asian market, including Japan.
In addition, Asian governments are developing new or more rigorous regulatory regimes to raise the quality of medical devices in their countries to international standards, in particular the implementation of the new Pharmaceutical Affairs Law in April 2005, and the new Market Authorization Holder system have changed the Japanese regulatory market.
This workshop highlights recent regulatory developments for medical devices in Japan and discusses changes in procedures such as:
• New requirements for foreign manufacturers
• Use of the MAH including subsidiaries
• New QMS requirements
• New PMS requirements
Course leader: Bernard Sweeney, General Manager, BSi Product Services, Healthcare, UK
|
|
Who Will You Meet
Past companies include:
- Abbott GmbH
- Agfa-Gevaert NV
- ALARIS Medical Systems
- Bausch & Lomb Inc
- Beckman Coulter
- Biosystems SA
- BOC Medical
- Boston Scientific International BV
- D Target
- Dade Behring SA
- Depuy International Ltd
- Elekta Ltd
- F Hoffmann La Roche Ltd
- Graseby Medical Ltd
- Johnson & Johnson
- Medtronic Ireland
- Microgen Bioproducts Ltd
- Molnlycke Health Care AB
- Novartis Pharma AG
- Pharmacia Ltd
- PLIVA Research Institute Ltd
- Smith & Nephew International
- St Jude Medical
- Stryker Europe
- William Cook Europe As
- Zimmer Ltd
|
|
|
|
|
|
|
|
|